Lipid-Based Ionic-Liquid-Mediated Nanodispersions as Biocompatible Carriers for the Enhanced Transdermal Delivery of a Peptide Drug.
ionic-liquid-in-oil nanodispersion
leuprolide acetate
lipid-based ionic liquids
pharmacokinetics and biocompatibility
stability
transdermal peptide delivery
Journal
ACS applied bio materials
ISSN: 2576-6422
Titre abrégé: ACS Appl Bio Mater
Pays: United States
ID NLM: 101729147
Informations de publication
Date de publication:
16 08 2021
16 08 2021
Historique:
entrez:
10
1
2022
pubmed:
11
1
2022
medline:
9
4
2022
Statut:
ppublish
Résumé
Lipid-based biocompatible ionic liquids (LBILs) have attracted attention as carriers in transdermal drug delivery systems (TDDSs) because of their lipophilic character. In this study, we report the formulation of a peptide-LBIL complex microencapsulated in an oil phase as a potential carrier for the transdermal delivery of leuprolide acetate as a model hydrophilic peptide. The peptide-LBIL complexes were prepared via a water-in-oil emulsion composed of 1,2-dimyristoyl-
Identifiants
pubmed: 35006923
doi: 10.1021/acsabm.1c00563
doi:
Substances chimiques
Drug Carriers
0
Ionic Liquids
0
Peptides
0
Surface-Active Agents
0
Water
059QF0KO0R
Linoleic Acid
9KJL21T0QJ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM